By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher today said that its board of directors has authorized a plan to repurchase $750 million of the firm's common stock.

The one-year plan would involve the firm acquiring shares of its common stock on the open market or in negotiated transactions.

Thermo Fisher said that it will offer approximately $750 million of senior notes to refinance outstanding indebtedness.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.